JP2016513651A5 - - Google Patents

Download PDF

Info

Publication number
JP2016513651A5
JP2016513651A5 JP2016502107A JP2016502107A JP2016513651A5 JP 2016513651 A5 JP2016513651 A5 JP 2016513651A5 JP 2016502107 A JP2016502107 A JP 2016502107A JP 2016502107 A JP2016502107 A JP 2016502107A JP 2016513651 A5 JP2016513651 A5 JP 2016513651A5
Authority
JP
Japan
Prior art keywords
mol
composition
lipid
cisplatin
peg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502107A
Other languages
English (en)
Japanese (ja)
Other versions
JP6077710B2 (ja
JP2016513651A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/026341 external-priority patent/WO2014160337A1/en
Publication of JP2016513651A publication Critical patent/JP2016513651A/ja
Publication of JP2016513651A5 publication Critical patent/JP2016513651A5/ja
Application granted granted Critical
Publication of JP6077710B2 publication Critical patent/JP6077710B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502107A 2013-03-13 2014-03-13 がん療法のためのリポソームシスプラチン組成物 Expired - Fee Related JP6077710B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361780272P 2013-03-13 2013-03-13
US61/780,272 2013-03-13
PCT/US2014/026341 WO2014160337A1 (en) 2013-03-13 2014-03-13 Liposomal cisplatin compositions for cancer therapy

Publications (3)

Publication Number Publication Date
JP2016513651A JP2016513651A (ja) 2016-05-16
JP2016513651A5 true JP2016513651A5 (https=) 2016-12-22
JP6077710B2 JP6077710B2 (ja) 2017-02-08

Family

ID=50439522

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502107A Expired - Fee Related JP6077710B2 (ja) 2013-03-13 2014-03-13 がん療法のためのリポソームシスプラチン組成物

Country Status (8)

Country Link
US (2) US10039716B2 (https=)
EP (1) EP2968142A1 (https=)
JP (1) JP6077710B2 (https=)
CN (1) CN105209017A (https=)
BR (1) BR112015022415A2 (https=)
CA (1) CA2903254C (https=)
MX (1) MX2015012199A (https=)
WO (1) WO2014160337A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5994049B2 (ja) * 2012-10-01 2016-09-21 兵神装備株式会社 吐出システム
EP3265063A4 (en) * 2015-03-03 2018-11-07 Cureport, Inc. Dual loaded liposomal pharmaceutical formulations
US9895313B2 (en) 2015-03-03 2018-02-20 Cureport, Inc. Combination liposomal pharmaceutical formulations
US20170049701A1 (en) * 2015-08-05 2017-02-23 Steven M. Kushner Clustoidal multilamellar soy lecithin phospholipid structures for transdermal, transmucosal, or oral delivery, improved intestinal absorption, and improved bioavailability of nutrients
US20180344644A1 (en) * 2015-09-21 2018-12-06 Mallinckrodt Llc Improved stability of liposome formulations and uses thereof
CN108136217B (zh) * 2016-01-07 2021-04-30 健康科学西部大学 用于治疗膀胱癌的制剂
ES2897983T3 (es) 2016-02-15 2022-03-03 Univ Georgia Liposomas cargados con IPA-3 y procedimientos de uso de los mismos
WO2017200957A1 (en) * 2016-05-16 2017-11-23 Infectious Disease Research Institute Pegylated liposomes and methods of use
US11331272B2 (en) * 2017-01-18 2022-05-17 Temasek Life Sciences Laboratory Limited Hyperstabilized liposomes increase targeting of mitotic cells
ES3062820T3 (en) 2017-11-08 2026-04-14 L E A F Holdings Group Llc Platinum complexes and uses thereof
EP4117686B1 (en) 2020-03-10 2024-12-04 Chung Yuan Christian University Liposome composition and preparation method thereof
TW202345843A (zh) * 2022-04-06 2023-12-01 財團法人國家衛生研究院 脂質奈米顆粒及脂質體

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843473A (en) * 1989-10-20 1998-12-01 Sequus Pharmaceuticals, Inc. Method of treatment of infected tissues
US20020009488A1 (en) * 1995-05-03 2002-01-24 Polymasc Pharmaceuticals Plc Tissue entrapment
ATE252372T1 (de) 1996-08-23 2003-11-15 Sequus Pharm Inc Liposome enthaltend cisplatin
CN1191067C (zh) 1997-02-05 2005-03-02 法玛西雅厄普约翰美国公司 高不溶性铂配合物的脂质复合物和脂质体
CA2398514A1 (en) * 2000-01-28 2001-08-02 Robert M. Abra Liposomes containing an entrapped compound in supersaturated solution
EP1341497A4 (en) * 2000-11-02 2005-10-19 Smithkline Beecham Corp RECEPTOR ANTAGONIST LIPID CONJUGATES AND DISPOSABLE SUPPLEMENTS CONTAINING THEM
AU2002340670A1 (en) 2001-11-13 2003-05-26 Celator Technologies, Inc. Lipid carrier compositions and methods for improved drug retention
EP1674081A1 (de) * 2004-12-23 2006-06-28 KTB Tumorforschungsgesellschaft mbH Herstellung von lipidbasierten Nanopartikeln unter Einsatz einer dualen asymmetrischen Zentrifuge
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
EP1716870A1 (en) * 2005-04-29 2006-11-02 Bracco Imaging S.p.A. MRI contrast agents endowed with concentration independent responsiveness
US20100034874A1 (en) 2006-12-08 2010-02-11 Katayama Chemical Industries Co., Ltd. Liposome encapsulating ammine-platinum complex at high concentration, and method for production of the liposome

Similar Documents

Publication Publication Date Title
JP2016513651A5 (https=)
JP6263508B2 (ja) 疾患修飾性抗リウマチ薬（ｄｍａｒｄ）および抗癌剤としてのメトトレキサートの持続性放出製剤
EP2344133B1 (en) A composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
JP2019006815A5 (https=)
RU2014120216A (ru) Комбинационные липосомальные композиции для лечения рака
CA2748520A1 (en) Pharmaceutical composition containing an anionic drug, and a production method therefor
JP6893245B2 (ja) 脂質ナノ粒子用膜材料組成物
WO2010009186A1 (en) Liposome formulation having hydrophilic and hydrophobic pharmaceutical compounds co-encapsulated therein
FI3821887T3 (fi) Mitoksantroni liposomin käyttö ei-hodgkinin lymfooman hoitoon
EP3861987A1 (en) Combination medicine comprising drug-encapsulating liposome composition and platinum preparation
JP2014506918A (ja) 抗腫瘍活性物質を含むリポソーム製剤、その調製のための方法、及び、それを含む医薬組成物
JP2019516693A5 (https=)
JP2018527335A5 (https=)
JP2009513621A (ja) リポソームを調製する方法及びその使用
JP2018500359A (ja) 表皮成長因子とリポソームのハイブリッド型多層ナノ構造体及びその製造方法
CN107708670A (zh) 磷脂包衣的治疗剂纳米颗粒和有关的方法
EP2231190B1 (en) Particulate drug carriers as desensitizing agents
JP6322575B2 (ja) 脂質マイクロカプセルのデリバリービヒクルを含む局所用製剤およびその使用
JP7590774B2 (ja) リポソームドキソルビシン製剤、リポソームドキソルビシン製剤の製造方法、および薬剤としてのリポソームドキソルビシン製剤の使用
US20160175250A1 (en) Method for Making Liposomes Containing an Active Pharmaceutical Ingredient
TWI391149B (zh) 小粒徑聚乙二醇化微脂體及其製備方法
WO2026088039A1 (en) Encapsulated apomorphine compositions
TW202302073A (zh) 包含帶電脂質的脂質製劑的組合物及製備方法
WO2016013031A1 (en) Liposome composition and method of preparing the liposome
WO2013131164A1 (pt) Composição farmacêutica contendo lipossomas convencionais e lipossomas de circulação prolongada para o tratamento da leishmaniose visceral